G1 phase growth arrest and induction of p21(Waf1/Cip1/Sdi1) in IB3-1 cells treated with 4-sodium phenylbutyrate

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 3, 2000, Pages 941-947

  McGrath Morrow, S A ^a   Stahl, J L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; ARYLBUTYRIC ACID DERIVATIVE; CELL DNA; PHENYLBUTYRATE 4 SODIUM; PROTEIN P21; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA CONTENT; DRUG MECHANISM; HUMAN; HUMAN CELL; INCUBATION TIME; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN INDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYSTIC FIBROSIS; G1 PHASE; HUMANS; PHENYLBUTYRATES;

EID: 0033847563     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells
2. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition
3. Urea cycle disorders: Diagnosis, pathophysiology, and therapy
4. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate
5. Cystic fibrosis: Molecular biology and therapeutic implications
6. Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: Structure-function analysis
7. Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea
8. WAF1, a potential mediator of p53 tumor suppression
9. Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells
10. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate
11. Transcriptional upregalation of gamma-globin by phenylbutyrate and analogous aromatic fatty acids
12. Cell-cycle control and its watchman [news; comment]
13. Gene redundancy and pharmacological gene therapy: Implications for X- linked adrenalenkodystrophy [see comments]
14. Induction of p21WAF/CIP1 during hyperoxia
15. Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo
16. O'Connor PM. (1997) Mammalian G1 and G2 phase checkpoints
17. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR
18. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: Partial restoration of nasal epithelial CFTR function
19. Use of protein repair therapy in the treatment of cystic fibrosis
20. p21 is necessary for the p53-mediated G1 arrest in human cancer cells
21. Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoic acid